Lab-Grown Meat: The Struggle for US Market Share

When the USDA granted approval to Upside Foods and GOOD Meat in June 2023, it felt like the starting gun for a food revolution. The promise was clear. We would soon eat real chicken and beef without slaughtering animals. However, over a year later, the average American consumer cannot find cultivated meat in grocery stores or fast-food chains. While regulatory hurdles have been cleared, the industry is now crashing into a much harder wall: the physics and economics of mass production.

The Scaling Paradox

The core of the issue lies in the transition from a laboratory setting to a factory floor. In the lab, scientists grow meat cells in small, controlled environments known as cultivators. Doing this in a 2-liter flask is manageable. Doing it in a 10,000-liter industrial steel tank is an entirely different engineering challenge.

Upside Foods, the California-based unicorn valued at over $1 billion, explicitly highlighted this struggle recently. The company paused its plans for a massive commercial facility in Glenview, Illinois, known as “Rubicon.” Instead of rushing toward massive tanks, they have retreated to their Engineering, Production, and Innovation Center (EPIC) in Emeryville to refine their process.

The technical difficulties are immense:

• Nutrient Distribution: In massive tanks, it is difficult to ensure cells in the center get the same oxygen and nutrients as cells near the edges.
• Sterility: A single speck of bacteria in a pharmaceutical-grade bioreactor can ruin tons of product instantly. Keeping a 50,000-liter tank perfectly sterile is exponentially harder than keeping a petri dish clean.
• Cell Density: To make money, companies need high cell density (more meat per liter of liquid). Currently, the industry struggles to reach densities that make the unit economics competitive with slaughtered chicken.

The Cost of Cultivation vs. Conventional Farming

Science is only half the battle. The other half is price. Conventional chicken is incredibly cheap to produce, often retailing for $2 to $5 per pound. While private companies rarely release exact production costs, industry analysts estimate that cultivated meat still costs hundreds of dollars per pound to produce.

When Upside Foods briefly sold its chicken at Bar Crenn in San Francisco, or when GOOD Meat served dishes at China Chilcano in Washington, D.C., the price on the menu did not reflect the cost of production. These were subsidized launches designed for marketing.

A major cost driver is the “growth medium,” the nutrient-rich soup the cells feed on. Historically, this required fetal bovine serum (FBS), which is expensive and derived from slaughtered cows. While Upside and others have developed animal-free serum alternatives, producing them at a price point that competes with cheap soy and corn feed used for livestock remains a significant hurdle.

Political Headwinds and State Bans

Even if Upside Foods solves the scaling issue, they face a shrinking map of where they can legally sell their product. The science of cultivated meat has become a political wedge issue in the United States.

In May 2024, Florida Governor Ron DeSantis signed SB 1084, effectively banning the sale and manufacturing of lab-grown meat in the state. Alabama followed shortly after with similar legislation. Lawmakers in these states argue the bans are necessary to protect the traditional agriculture industry and question the long-term safety of the product, despite FDA clearance.

This creates a fragmented market. A national rollout is impossible if major retailers cannot stock the product in the third-most populous state. It forces companies to fight legal battles on a state-by-state basis while simultaneously trying to invent new manufacturing techniques.

The "Valley of Death" for Food Tech

The sector is currently traversing what venture capitalists call the “valley of death.” This is the period between creating a working prototype (the USDA-approved chicken) and reaching commercial viability.

Investment capital has tightened significantly. In 2021 and 2022, money poured into food tech. In 2024, interest rates are higher, and investors want to see profitable unit economics, not just scientific milestones. Upside Foods conducted layoffs in early 2024, signaling a pivot from rapid expansion to survival and research.

Competitors are in similar boats. GOOD Meat is facing legal battles with its bioreactor supplier, bioreactor manufacturer ABEC, over unpaid bills. The exuberant optimism of 2023 has been replaced by a grim determination to simply make the math work.

What Comes Next?

The path forward for Upside Foods and its peers is likely a hybrid approach. Rather than 100% cultivated filets, the first mass-market products will likely be blended items. Imagine a chicken nugget that is 20% cultivated cells and 80% plant-based protein.

This strategy achieves two things:

1. Lowers Cost: Plant proteins are cheap.
2. Improves Texture: Plant structures can provide the “bite” that unstructured cell paste lacks.

For now, the science is proven, but the business model is still in beta. The struggle for US market share is no longer about proving meat can be grown in a lab. It is about proving it can be done without bankrupting the company.

Frequently Asked Questions

Is lab-grown meat currently for sale in grocery stores? No. As of late 2024, you cannot buy cultivated meat in US grocery stores. It has been available strictly at select partner restaurants for limited engagements, but widespread retail distribution is years away.

Is lab-grown meat the same as Impossible or Beyond Meat? No. Impossible and Beyond burgers are plant-based (made from soy, peas, and potato proteins). Lab-grown meat, also called cultivated meat, is biologically identical to animal meat. It is grown from actual animal cells, not plants.

Why did Florida ban lab-grown meat? Florida officials cited the protection of the state’s cattle and farming industries as a primary reason. They also expressed skepticism regarding the “social experiment” of replacing traditional farming with factory-produced food.

Is it safe to eat? According to the FDA and USDA, yes. Both agencies completed rigorous pre-market consultations with Upside Foods and GOOD Meat, concluding that the chicken is safe for human consumption.

How long until it costs the same as regular meat? Estimates vary, but most experts believe price parity is at least 5 to 10 years away. It requires massive technological leaps in bioreactor efficiency and cheap nutrient sourcing.